Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Vaccines and Guillain-Barré syndrome.

Haber P, Sejvar J, Mikaeloff Y, DeStefano F.

Drug Saf. 2009;32(4):309-23. doi: 10.2165/00002018-200932040-00005. Review.

PMID:
19388722
2.

Guillain-Barré syndrome.

Yuki N, Hartung HP.

N Engl J Med. 2012 Jun 14;366(24):2294-304. doi: 10.1056/NEJMra1114525. Review. No abstract available. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

PMID:
22694000
3.

Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.

Xia RH, Yosef N, Ubogu EE.

J Neuroimmunol. 2010 Feb 26;219(1-2):54-63. doi: 10.1016/j.jneuroim.2009.11.019. Epub 2010 Jan 19.

PMID:
20034679
4.

Guillain-Barré syndrome: epidemiology, pathophysiology and management.

Kuwabara S.

Drugs. 2004;64(6):597-610. Review.

PMID:
15018590
5.

Intravenous immunoglobulin for Guillain-Barré syndrome.

Hughes RA, Swan AV, van Doorn PA.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002063. doi: 10.1002/14651858.CD002063.pub5. Review. Update in: Cochrane Database Syst Rev. 2014;(9):CD002063.

PMID:
22786476
6.

Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome.

van Doorn PA, Ruts L, Jacobs BC.

Lancet Neurol. 2008 Oct;7(10):939-50. doi: 10.1016/S1474-4422(08)70215-1. Review.

PMID:
18848313
7.

Guillain-Barré syndrome.

Hughes RA, Cornblath DR.

Lancet. 2005 Nov 5;366(9497):1653-66. Review.

PMID:
16271648
8.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.

JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.

PMID:
22782419
9.

Multidisciplinary care for Guillain-Barré syndrome.

Khan F, Ng L, Amatya B, Brand C, Turner-Stokes L.

Eur J Phys Rehabil Med. 2011 Dec;47(4):607-12. Epub 2011 Sep 13. Review.

10.

Rehabilitation of Guillain-Barré syndrome.

Meythaler JM.

Arch Phys Med Rehabil. 1997 Aug;78(8):872-9. Review.

PMID:
9344309
11.

Guillain-Barré syndrome.

Rosen BA.

Pediatr Rev. 2012 Apr;33(4):164-70; quiz 170-1. doi: 10.1542/pir.33-4-164. Review.

PMID:
22474113
12.

Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barré syndrome: a randomized controlled trial.

Khan F, Pallant JF, Amatya B, Ng L, Gorelik A, Brand C.

J Rehabil Med. 2011 Jun;43(7):638-46. doi: 10.2340/16501977-0826.

13.

Treatment of Guillain-Barré syndrome: a review.

Rajabally YA.

Inflamm Allergy Drug Targets. 2012 Aug 1;11(4):330-4. Review.

PMID:
22452606
14.

Plasma exchange for Guillain-Barré syndrome.

Raphaël JC, Chevret S, Hughes RA, Annane D.

Cochrane Database Syst Rev. 2002;(2):CD001798. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD001798.

PMID:
12076424
15.

IVIG treatment and prognosis in Guillain-Barré syndrome.

van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC.

J Clin Immunol. 2010 May;30 Suppl 1:S74-8. doi: 10.1007/s10875-010-9407-4. Review.

16.

Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome.

Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, Kuwabara S.

Brain. 2003 Oct;126(Pt 10):2279-90. Epub 2003 Jul 7. Review.

PMID:
12847079
17.

Outcome and its predictors in Guillain-Barre syndrome.

Rajabally YA, Uncini A.

J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):711-8. doi: 10.1136/jnnp-2011-301882. Epub 2012 May 7. Review.

PMID:
22566597
18.

Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.

Uncini A, Kuwabara S.

Clin Neurophysiol. 2012 Aug;123(8):1487-95. doi: 10.1016/j.clinph.2012.01.025. Epub 2012 Apr 4. Review.

PMID:
22480600
19.

Corticosteroids for Guillain-Barré syndrome.

Hughes RA, van Doorn PA.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD001446. doi: 10.1002/14651858.CD001446.pub4. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 24;10 :CD001446.

PMID:
22895921
20.

Intravenous immunoglobulin for Guillain-Barré syndrome.

Hughes RA, Swan AV, van Doorn PA.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD002063. doi: 10.1002/14651858.CD002063.pub4. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002063.

PMID:
20556755

Supplemental Content

Support Center